Adams (NY)
{name}
{subtitle}
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
city
~46 mi. (Oswego, New York, +235 more cities)
facility
Upstate Cancer Center Radiation Oncology at Oswego
condition
Prostate Adenocarcinoma
drug
abiraterone, +9 more drugs
drug type
hormone therapy, +2 more types
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~46 mi. (Oswego, New York, +469 more cities)
facility
Upstate Cancer Center Radiation Oncology at Oswego
condition
Non-Small Cell Lung Carcinoma
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
city
~46 mi. (Oswego, New York, +88 more cities)
facility
Upstate Cancer Radiation Oncology at Oswego, +1 more facility
condition
Prostate Adenocarcinoma
drug
enzalutamide, +2 more drugs
drug type
hormone therapy, +1 more type
Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer
city
~50 mi. (Kingston, Canada, +153 more cities)
facility
Kingston Health Sciences Centre -- Hotel Dieu Hospital, +2 more facilities
condition
Bladder Urothelial Carcinoma, +2 more conditions
drug
BCG solution, +1 more drug
drug type
immunotherapy
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~50 mi. (Kingston, Canada, +240 more cities)
facility
Kingston Health Sciences Centre
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~50 mi. (Kingston, Canada, +159 more cities)
facility
Kingston Health Sciences Centre ( Site 0103)
condition
Superficial Bladder Urothelial Carcinoma
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
city
~50 mi. (Kingston, Canada, +199 more cities)
facility
Research Site
condition
Hepatocellular Carcinoma
drug
bevacizumab, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
city
~50 mi. (Kingston, Canada, +314 more cities)
facility
Kingston Health Sciences Centre, Kingston General Health Research Institute
biomarker
ATM Loss, +61 more biomarkers
condition
Prostate Adenocarcinoma
drug
abiraterone, +2 more drugs
drug type
hormone therapy, +1 more type